Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $303,367 - $364,435
3,456 New
3,456 $357,000
Q1 2023

May 16, 2023

BUY
$132.34 - $159.14 $3.71 Million - $4.46 Million
28,022 New
28,022 $4.46 Million
Q3 2020

Nov 16, 2020

SELL
$63.69 - $70.22 $1.2 Million - $1.32 Million
-18,800 Reduced 48.25%
20,167 $1.4 Million
Q2 2020

Aug 14, 2020

SELL
$58.54 - $67.94 $2.2 Million - $2.55 Million
-37,533 Reduced 49.06%
38,967 $2.55 Million
Q4 2019

Feb 14, 2020

SELL
$49.86 - $58.26 $673,259 - $786,684
-13,503 Reduced 15.0%
76,500 $4.43 Million
Q3 2019

Nov 14, 2019

BUY
$47.54 - $53.43 $3.57 Million - $4.01 Million
75,104 Added 504.09%
90,003 $4.65 Million
Q1 2019

May 15, 2019

BUY
$46.36 - $52.63 $690,717 - $784,134
14,899 New
14,899 $779,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Susquehanna International Securities, Ltd. Portfolio

Follow Susquehanna International Securities, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Securities, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Securities, Ltd. with notifications on news.